Skip to main content
. 2022 Sep 11;12(15):6576–6594. doi: 10.7150/thno.78034

Figure 9.

Figure 9

BEVs-based immunotherapy and photothermal therapy. (A-B) Schematic illustration of BEV-Mel production. Adapted with permission from 35, copyright 2019, Springer Nature. (C-D) Schematic illustration of the construction of HPDA@BEV-CC NPs and their antitumor immune responses after PTT. Adapted with permission from 99, copyright 2020, American Chemical Society.